Aardvark Therapeutics, Inc. · Brief

Next report

12 days

Nov 12 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±75.0%implied · straddle

0.342.38

spot 1.36exp Nov 20ATM strike 2.5ATM straddle 1.20IV 183%

Oct 30 close

Expected move

Inputs

Implied vs realized

7 reportsHistory

—≥ implied

Mar 31 '25—▲+10.39%—

May 14 '25—▲+4.00%—

Aug 13 '25—▲+0.54%—

Q3 FY25—▼−8.66%—

Q1 FY26±89.9%▼−7.26%×0.08

May 7 '26±56.7%▼−4.92%×0.09

Q2 FY26±54.2%▼−8.62%×0.16

quarterimplied−90%0+90%realized×

Q2 FY26±54.2%▼−8.62%×0.16

May '26±56.7%▼−4.92%×0.09

Q1 FY26±89.9%▼−7.26%×0.08

Q3 FY25—▼−8.66%—

Aug '25—▲+0.54%—

May '25—▲+4.00%—

Mar '25—▲+10.39%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2

3 of 3recent reports where the move came in under the options implied rangeEarnings history

71managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

6managers whose positions together make up the majority of reported value13F · Jun 30 '26

10 of 22largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

AARD report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 29impliedImplied move: ±67.9% into Nov 12 earnings (Oct 29 close).Source

Oct 23haltTrading halt: 09:51 ET, resumed 09:56 ET.Source

Oct 23haltTrading halt: 09:45 ET, resumed 09:50 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.